Dermapharm Holding SE (LON:0A5J)

Market Cap	1.69B +9.3%
Revenue (ttm)	1.02B +0.4%
Net Income	126.18M +36.7%
EPS	2.39 +39.0%
Shares Out	n/a
PE Ratio	13.36
Forward PE	13.43
Dividend	0.77 (2.30%)
Ex-Dividend Date	Jun 29, 2026

Volume	6,819
Open	37.20
Previous Close	38.95
Day's Range	38.70 - 39.53
52-Week Range	31.85 - 51.70
Beta	0.85
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About Dermapharm Holding SE

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China. The company operates through three segments: Branded Pharmaceuticals; Other Healthcare Products; and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company a...

• Industry: Pharmaceutical Preparations
• Founded: 1991
• Employees: 3,619
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0A5J

Financial Performance

In 2025, Dermapharm Holding SE's revenue was 1.17 billion, a decrease of -1.32% compared to the previous year's 1.18 billion. Earnings were 132.41 million, an increase of 16.37%.

Financial numbers in EUR

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 6, 2026

Data Sources Report a data error